Clinical Overview
Nortriptyline is a tricyclic antidepressant indicated for the treatment of depression. It is the active metabolite of amitriptyline and is often preferred among tricyclics due to its more favorable side effect profile, particularly lower sedation and anticholinergic effects compared to other tricyclic antidepressants.
Primary Clinical Applications
Nortriptyline is indicated for depression treatment and is commonly used off-label for chronic pain conditions, migraine prevention, and neuropathic pain. It is often chosen when a tricyclic is needed but better tolerability is desired compared to amitriptyline.
Mechanism and Clinical Benefits
Nortriptyline primarily inhibits norepinephrine reuptake with some serotonin reuptake inhibition. This mechanism provides antidepressant effects and analgesic properties for chronic pain conditions. It has a well-defined therapeutic window for plasma levels.
Therapeutic Monitoring
Nortriptyline has established therapeutic plasma level ranges (50-150 ng/mL), allowing for therapeutic drug monitoring to optimize efficacy and minimize toxicity. This monitoring capability is particularly valuable in elderly patients or those with medical comorbidities.
Prescribing Information
Dosing & Administration
Depression – Adults:
- Initial: 25 mg 3-4 times daily
- Alternative: 75-100 mg daily at bedtime
- Maintenance: 75-100 mg daily
- Maximum: 150 mg daily
Elderly/Adolescents:
- Initial: 10-25 mg daily at bedtime
- Maintenance: 25-75 mg daily
Chronic Pain (off-label):
- Initial: 10-25 mg at bedtime
- Target: 50-75 mg daily
Indications
- Depression
- Off-label: Chronic pain, neuropathic pain, migraine prevention
Contraindications
- Recent myocardial infarction
- MAOI use within 14 days
- Known hypersensitivity to tricyclic antidepressants
- Concurrent use with linezolid or methylene blue
Warnings & Precautions
- Boxed Warning: Increased suicidal risk in patients under 25 years
- Cardiac effects: Monitor ECG in patients with cardiac disease
- Anticholinergic effects: Use caution in elderly patients
- Seizure risk: Lower seizure threshold
- Orthostatic hypotension: Monitor blood pressure
Drug Interactions
- MAOIs: Contraindicated – risk of serotonin syndrome
- CNS depressants: Enhanced sedation
- Anticholinergic drugs: Additive anticholinergic effects
- CYP2D6 inhibitors: Increased nortriptyline levels
- Sympathomimetics: Enhanced pressor response
Adverse Reactions
Common:
- Dry mouth, constipation, blurred vision, drowsiness
Cardiovascular:
- Orthostatic hypotension, tachycardia, conduction abnormalities
Special Populations
- Pregnancy: Category D – avoid if possible
- Elderly: Lower starting dose, monitor for anticholinergic effects
- Cardiac disease: Obtain baseline ECG, monitor closely
- CYP2D6 poor metabolizers: Reduced dosing may be needed
Medical Disclaimer: This information is for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare professionals before making any treatment decisions. Individual patient circumstances may vary significantly.
